Provectus Biopharmaceuticals, Inc.
PVCT
$0.088
$0.008110.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.15% | 27.00% | 63.95% | 533.45% | 64.44% |
| Total Receivables | -- | -- | -- | -- | 700.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.06% | -63.94% | 234.02% | -30.64% | -14.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -58.15% | -54.25% | -57.28% | -23.76% | -24.84% |
| Total Current Assets | -12.50% | -33.51% | 28.53% | -5.02% | -20.68% |
|
|
|||||
| Total Current Assets | -12.50% | -33.51% | 28.53% | -5.02% | -20.68% |
| Net Property, Plant & Equipment | 817.26% | -43.05% | -29.76% | -25.27% | -19.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.42% | -33.79% | 25.47% | -6.35% | -20.63% |
|
|
|||||
| Total Accounts Payable | 76.21% | -32.77% | -19.87% | 4.47% | -3.51% |
| Total Accrued Expenses | 17.62% | 0.36% | 38.78% | -52.20% | 8.98% |
| Short-term Debt | -56.42% | -39.66% | 86.88% | 0.55% | -42.43% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.93% | -17.65% | 10.69% | -8.42% | -1.80% |
| Total Finance Division Other Current Liabilities | -- | -82.89% | -4.08% | -23.86% | -35.65% |
| Total Other Current Liabilities | -- | -82.89% | -4.08% | -23.86% | -35.65% |
| Total Current Liabilities | 13.22% | -17.78% | 12.06% | -25.63% | -1.72% |
|
|
|||||
| Total Current Liabilities | 13.22% | -17.78% | 12.06% | -25.63% | -1.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -56.42% | -39.66% | 86.88% | 0.55% | -42.43% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.03% | -17.78% | 12.06% | -25.63% | -1.87% |
|
|
|||||
| Common Stock & APIC | 0.41% | 0.79% | 0.73% | 1.26% | 0.32% |
| Retained Earnings | -0.70% | -0.44% | -0.93% | -0.40% | -0.33% |
| Treasury Stock & Other | 0.49% | 0.00% | -0.83% | 0.50% | 0.17% |
| Total Common Equity | -15.02% | 14.33% | -9.87% | 27.76% | -0.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.08% | 2.13% | 0.71% | 7.69% | -43.48% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.08% | 2.13% | 0.71% | 7.69% | -43.48% |
|
|
|||||
| Total Common Equity | -15.02% | 14.33% | -9.87% | 27.76% | -0.71% |
| Total Preferred Equity | 2.08% | 2.13% | 0.71% | 7.69% | -43.48% |
| Total Minority Interest | -111.24% | 441.41% | -- | -- | -- |
| Total Equity | -15.90% | 15.08% | -10.08% | 27.82% | -0.85% |
|
|
|||||